Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast ...

The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.

The Danaher subsidiary aims to meet clinician needs for flexibility with a range of test size options for its vast installed base.

SUNNYVALE, Calif., April 3, 2024 /PRNewswire/ -- Cepheid today announced that Xpert ® HIV-1 Qual XC has been awarded World Health Organization (WHO) prequalification. Inclusion on the prequalification ...

These include fast, accurate, and easy to use tests for SARS-CoV-2, the virus causing COVID-19, Flu, MRSA, tuberculosis, and other HAI, sexual health, and oncology diseases. Each test is designed for ...

New agreement aims to provide greater access to millions more high-quality tuberculosis (TB) tests for people living in the least developed countries where the need is most urgent. Enables the Global ...

(Reuters) - The World Health Organization said on Wednesday it has listed two additional mpox in-vitro diagnostic tests for emergency use. Xpert Mpox, a real-time PCR test manufactured by Cepheid, was ...

(Reuters) - The U.S. Food and Drug Administration granted marketing approval to Cepheid's tuberculosis test that checks if the disease-causing bacteria carry antibiotic-resistant genetic markers. The ...

Cepheid, a medical device and biotech company based in Sunnyvale, Calif., plans to lay off 686 workers by June 20, according to notices filed with the state. The company, which makes PCR diagnostic ...